An2 Therapeutics Stock Price on October 23, 2024
| ANTX Stock | USD 1.39 0.05 3.73% |
If you're considering investing in AN2 Stock, it is important to understand the factors that can impact its price. As of today, the current price of AN2 Therapeutics stands at 1.39, as last reported on the 26th of November, with the highest price reaching 1.45 and the lowest price hitting 1.35 during the day. AN2 Therapeutics appears to be slightly risky, given 3 months investment horizon. AN2 Therapeutics retains Efficiency (Sharpe Ratio) of 0.11, which signifies that the company had a 0.11% return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for AN2 Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of AN2 Therapeutics' Market Risk Adjusted Performance of 0.476, coefficient of variation of 1047.82, and Standard Deviation of 3.62 to double-check if our risk estimates are consistent with your expectations.
At this time, AN2 Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 292.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 21.8 M in 2024. . Price Earnings Ratio is likely to drop to -7.84 in 2024. Price Book Value Ratio is likely to drop to 3.68 in 2024. AN2 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
AN2 |
Sharpe Ratio = 0.1066
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ANTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.66 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average AN2 Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AN2 Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.4567 | Book Value 4.193 | Enterprise Value -55.2 M | Enterprise Value Ebitda (2.11) | Shares Float 11.4 M |
Related Headline
Pmv Pharmaceuticals Headline on 23rd of October 2024
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE C... by finance.yahoo.com
Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors more than 75 percent of sites activated across the U.S., Europe, and Asia-Pacific interim analysis expected by mid-2025 Dose-limiting toxicities observed in rezatapopt and Mercks anti-PD-1 therapy KEYTRUDA combination arm of Phase 1b PYNNACLE trial rezatapopt 500 mg once-daily in combination with pe
AN2 Therapeutics Valuation on October 23, 2024
It is possible to determine the worth of AN2 Therapeutics on a given historical date. On October 23, 2024 AN2 was worth 1.08 at the beginning of the trading date compared to the closed value of 1.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AN2 Therapeutics stock. Still, in general, we apply an absolute valuation method to find AN2 Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AN2 Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AN2 Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.07 | 1.10 | 1.06 | 1.08 | 178,807 | |
10/23/2024 | 1.08 | 1.09 | 1.06 | 1.08 | 133,466 |
| 1.09 | 1.09 | 1.07 | 1.07 | 97,763 |
| Backtest AN2 Therapeutics | | | AN2 Therapeutics History | | | AN2 Therapeutics Valuation | Previous | Next |
AN2 Therapeutics Trading Date Momentum on October 23, 2024
| On October 24 2024 AN2 Therapeutics was traded for 1.07 at the closing time. The top price for the day was 1.09 and the lowest listed price was 1.07 . The trading volume for the day was 97.8 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.93% . The overall trading delta against the current closing price is 0.00% . |
AN2 Therapeutics Fundamentals Correlations and Trends
By evaluating AN2 Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AN2 Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AN2 financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AN2 Therapeutics Stock history
AN2 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AN2 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AN2 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AN2 Therapeutics stock prices may prove useful in developing a viable investing in AN2 Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 23.6 M | 21.8 M | |
| Net Loss | -38.5 M | -40.4 M |
AN2 Therapeutics Quarterly Net Working Capital |
|
AN2 Therapeutics Stock Technical Analysis
AN2 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AN2 Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
AN2 Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
AN2 Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how AN2 Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AN2 Therapeutics shares will generate the highest return on investment. By undertsting and applying AN2 Therapeutics stock market strength indicators, traders can identify AN2 Therapeutics entry and exit signals to maximize returns
AN2 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AN2 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AN2 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AN2 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0811 | |||
| Jensen Alpha | 0.2483 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.0758 | |||
| Treynor Ratio | 0.466 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for AN2 Stock Analysis
When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.